BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 18952090)

  • 21. 5-HT2C receptor involvement in female rat lordosis behavior.
    Wolf A; Caldarola-Pastuszka M; DeLashaw M; Uphouse L
    Brain Res; 1999 Apr; 825(1-2):146-51. PubMed ID: 10216181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT1A receptor antagonists and lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
    Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
    Selvamani A; Lincoln C; Uphouse L
    Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dilute estradiol implants and progestin receptor induction in the ventromedial nucleus of the hypothalamus: correlation with receptive behavior in female rats.
    Pleim ET; Brown TJ; MacLusky NJ; Etgen AM; Barfield RJ
    Endocrinology; 1989 Apr; 124(4):1807-12. PubMed ID: 2924724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allopregnanolone's attenuation of the lordosis-inhibiting effects of restraint is blocked by the antiprogestin, CDB-4124.
    Uphouse L; Hiegel C
    Pharmacol Biochem Behav; 2014 Jul; 122():16-9. PubMed ID: 24650591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action.
    Jackson A; Uphouse L
    Brain Res; 1998 Jun; 796(1-2):299-302. PubMed ID: 9689482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An antiprogestin, CDB4124, blocks progesterone's attenuation of the negative effects of a mild stress on sexual behavior.
    Uphouse L; Hiegel C
    Behav Brain Res; 2013 Mar; 240():21-5. PubMed ID: 23153933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Jackson A; Uphouse L
    Horm Behav; 1996 Jun; 30(2):145-52. PubMed ID: 8797023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of progesterone on serotonin turnover in rats primed with estrogen implants into the ventromedial hypothalamus.
    Gereau RW; Kedzie KA; Renner KJ
    Brain Res Bull; 1993; 32(3):293-300. PubMed ID: 7690679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized actions of progesterone in hypothalamus involve oxytocin.
    Schumacher M; Coirini H; Frankfurt M; McEwen BS
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6798-801. PubMed ID: 2549547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior.
    Maswood N; Caldarola-Pastuszka M; Uphouse L
    Brain Res; 1998 Aug; 802(1-2):98-103. PubMed ID: 9748522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint II. Role of progesterone metabolites.
    Miryala CS; Hassell J; Adams S; Hiegel C; Uzor N; Uphouse L
    Horm Behav; 2011 Jul; 60(2):226-32. PubMed ID: 21621542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological evidence that 5-HT(1B/1D) receptors mediate hypotension in anesthetized rats.
    Terrón JA; Sánchez-Maldonado C; Martínez-García E
    Eur J Pharmacol; 2007 Dec; 576(1-3):132-5. PubMed ID: 17727836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha 1-adrenergic agonists act on the ventromedial hypothalamus to cause neuronal excitation and lordosis facilitation: electrophysiological and behavioral evidence.
    Kow LM; Weesner GD; Pfaff DW
    Brain Res; 1992 Aug; 588(2):237-45. PubMed ID: 1356590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated estradiol benzoate treatment protects against the lordosis-inhibitory effects of restraint and prevents effects of the antiprogestin, RU486.
    Uphouse L; Hiegel C; Martinez G; Solano C; Gusick W
    Pharmacol Biochem Behav; 2015 Oct; 137():1-6. PubMed ID: 26190222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic GMP may potentiate lordosis behaviour by progesterone receptor activation.
    Chu HP; Morales JC; Etgen AM
    J Neuroendocrinol; 1999 Feb; 11(2):107-13. PubMed ID: 10048465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of delta-opioid receptors in estrogen facilitation of lordosis behavior.
    Acosta-Martinez M; Etgen AM
    Behav Brain Res; 2002 Oct; 136(1):93-102. PubMed ID: 12385794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of estrogen treatment on scopolamine inhibition of lordosis.
    Menard CS; Hebert TJ; Ross SM; Dohanich GP
    Horm Behav; 1992 Sep; 26(3):364-74. PubMed ID: 1398555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild restraint reduces the time hormonally primed rats spend with sexually active males.
    Uphouse L; Selvamani A; Lincoln C; Morales L; Comeaux D
    Behav Brain Res; 2005 Feb; 157(2):343-50. PubMed ID: 15639185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apelin-13 facilitates lordosis behavior following infusions to the ventromedial hypothalamus or preoptic area in ovariectomized, estrogen-primed rats.
    García-Juárez M; Luna-Hernández A; Tapia-Hernández S; Montes-Narvaez O; Domínguez-Ordoñez R; Tecamachaltzi-Silvarán MB; Pfaus JG; González-Flores O
    Neurosci Lett; 2022 Mar; 773():136518. PubMed ID: 35150776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.